Introduction {#section5-2515841419835339}
============

Blindness is an important source of fear in the elderly second only to death. Cataract is one of the main causes of vision loss.^[@bibr1-2515841419835339]^ It is defined as clouding of the lens and is one of the most common preventable causes of disability in the elderly in developing and developed countries.^[@bibr2-2515841419835339][@bibr3-2515841419835339]--[@bibr4-2515841419835339]^

Approximately 285 million people are suffering from visual impairment, more than 39 million of whom are blind. Despite the implementation of the 'Vision 2020' program for reduction of preventable visual disorders, refractive disorders and cataract are still responsible for 80% of the causes of visual impairment in the world. Half of them are due to cataract.^[@bibr5-2515841419835339][@bibr6-2515841419835339]--[@bibr7-2515841419835339]^

In a study carried out in the rural areas in north-east of Iran, 17.6% of cases with visual impairment were due to cataract.^[@bibr7-2515841419835339]^ Also, cataract with 30.7% was the leading cause of visual impairment in Saudi adults.^[@bibr8-2515841419835339]^ In a study in Nepal, frequency of cataract in subjects over 60 years with bilateral low vision was 68.07%.^[@bibr9-2515841419835339]^

In Peru, the age--sex standardized prevalence of bilateral blindness was estimated at 2.1%.^[@bibr10-2515841419835339]^ Results of a study conducted in Iran showed different prevalences of cataract regarding sex. It also revealed a higher chance of developing nuclear, cortical, and posterior subcapsular cataract (PSC) among smokers compared with nonsmokers.^[@bibr11-2515841419835339]^

There are no sufficient evidences in case of prevalence and related factors of cataract among Iranian elderly. Considering the extent of geographical, climatic, cultural, and ethnical situation of Iran, estimating the sex--age standardized prevalence of cataract as well as relevant risk factors is necessary. Such information provides reliable evidences which are suitable for planning preventive programs as well as designing appropriate analytic researches. This study aimed to estimate crude and standardized prevalence of cataract and its associated factors among elderly population in northern Iran.

Methods {#section6-2515841419835339}
=======

This cross-sectional study was carried out in a 'day clinic' (a clinic with limited services and facilities) in northern Iran (Mazandaran-Chaloos). The most patients referred to this clinic were patients from Chaloos and Noshahr in Western Mazandaran province including 111,542 and 138,913 population, respectively.

This study was conducted based on the Declaration of Helsinki. The study was approved by Mazandaran University of Medical Science Ethics Committee (Ethical Code: 546). Informed consents were obtained from all participants. A grant for this study was provided by Student Research Committee of this institute.

The study population was aged 60 and older. The required sample size for the detection of 50% (maximum prevalence), 95% confidence level, and accuracy of 0.05 based on the one-sample proportion formula was estimated at 397. Using the consensus method, from January 2016, the target population was entered into the study until providing the required sample size which was ended in May 2016. The information was collected using a checklist designed based on the available literature. The checklist included questions regarding demographic characteristics, history of communicable and noncommunicable diseases, ophthalmic problems other than cataract, history of ophthalmic surgery, history of blunt ophthalmic trauma, history of daily consumption of corticosteroids, vitamin supplementations (B, C, E), and sedatives (at least 6 months), daily fat consumption, daily fruit/vegetable consumption, history of alcohol consumption and cigarette smoking, history of working in open places or living in tropical areas of southern Iran, daily exercise, history of frequent X-ray imaging of the head, history of contact lens use, using personal antisolar protective instruments such as hat and glasses, familial history of cataract, residence area (urban/rural), and history of having cataract (operated and non-operated).

Statistical analysis {#section7-2515841419835339}
--------------------

Data analysis was performed using SPSS version 22 software (SPSS Inc., Chicago, IL, USA). Study variables were described as percent frequency, mean, standard deviation, minimum, and maximum. Mean age of the participants was compared between groups using independent *t* test. Frequency of categorical variables was compared between groups using chi-square test. Multiple logistic regression models were applied to estimate the effect of different variables controlling for potential confounders. All variables showing significant association with cataract in the univariate models (*p* \< 0.1) were entered into the multivariate models. The goodness of fit for these models was assessed using Nagelkerke's *R*^2^. To adjust the effect of age and sex on the prevalences, direct standardized prevalences were estimated based on Segi's World Standard Population per 100,000.^[@bibr12-2515841419835339]^

Results {#section8-2515841419835339}
=======

Totally, 397 patients aged over 60 referring to Imam Reza day clinic in Chaloos, Mazandaran (northern Iran) were recruited in the study. Of them, 205 (51.6%) were female. Mean, standard deviation, minimum, and maximum age for them were 69.1, 7.1, 60, and 90 years, respectively. Men were slightly older than women, but the difference was not statistically significant (69.17 ± 7.16 *versus* 69.04 ± 7.02, *p* = 852).

Crude prevalences of cataract among men, women, and all population were 28.6%, 31.2%, and 29.9%, respectively. Controlling for age and sex, the standardized prevalences \[95% confidence intervals (CIs)\] were 27.5% (21.2--33.8), 30.9% (24.5--37.4), and 29.1% (24.6--33.6), respectively. The observed difference regarding sex was not statistically significant (*p* = 0.576). The affected eye was the left eye in 23 (5.8%), right eye in 26 (6.5%), and both eyes in 70 (17.6%) patients. Mean \[standard deviation (SD)\] ages of those with and without cataract were 71.07 (7.72) and 68.25 (6.62) years, respectively (*p* = 0.001). Mean (SD) body mass indexes (BMIs) for patients with and without cataract were 26.54 (4.92) and 26.21 (3.94), respectively (*p* = 0.483).

Based on the results of univariate analyses, prevalence of cataract was higher among rural residents than urban residents (33.3% *versus* 27.8%, respectively, *p* = 0.240), obese patients than normal BMI patients (35.7% *versus* 26.8%, respectively, *p* = 0.374), low-income persons than high-income ones (36.7% *versus* 28.6%, respectively, *p* = 0.100), diabetic patients than nondiabetics (72.4% *versus* 19.9%, respectively, *p* \< 0.001), hypertensive patients than normotensives (60.8% *versus* 20%, respectively, *p* \< 0.001), and patients with rheumatoid arthritis than those without (76% *versus* 26.9%, respectively, *p* \< 0.001). Details of the other investigated factors are presented in [Table 1](#table1-2515841419835339){ref-type="table"}.

###### 

Characteristics of patients with and without cataract.

![](10.1177_2515841419835339-table1)

  Variables                                  Total number                   Cataract            *p* value (chi-square)                        
  ------------------------------------------ ------------------------------ ------------------- ------------------------ ------ ------ ------ ---------
  Sex                                        Male                           192                 55                       28.6   137    71.4   0.576
                                             Female                         205                 64                       31.2   141    68.8   
  Age group                                  60--64                         117                 27                       23.1   90     76.9   0.006
                                             65--69                         116                 27                       23.3   89     76.7   
                                             70--74                         78                  30                       38.5   48     61.5   
                                             ⩾70                            86                  35                       40.7   51     59.3   
  Area of residence                          Urban                          241                 67                       27.8   174    72.2   0.240
                                             Rural                          156                 52                       33.3   104    66.7   
  BMI                                        ⩽25                            168                 45                       26.8   123    73.2   0.374
                                             25--29.9                       159                 49                       30.8   110    69.2   
                                             ⩾30                            45                  25                       35.7   45     64.3   
  Education                                  Illiterate                     130                 49                       37.7   81     62.3   0.036
                                             Primary education to diploma   188                 53                       28.2   135    71.8   
                                             Higher diploma                 79                  17                       21.5   62     78.5   
  Job                                        Employee                       161                 37                       23     124    77     0.012
                                             Housewife                      125                 49                       39.2   76     60.8   
                                             Retired                        111                 33                       29.7   78     70.3   
  Income level                               Less than spending             139                 51                       36.7   88     63.3   0.100
                                             Equal to spending              251                 66                       26.3   185    73.7   
                                             More than spending             7                   2                        28.6   5      71.4   
  Living condition                           Living alone                   57                  27                       47.4   30     52.6   0.008
                                             Lives with wife                139                 39                       28.1   100    71.9   
                                             Lives with wife and children   201                 53                       26.4   148    73.6   
  Diabetes                                   Yes                            76                  55                       72.4   21     27.6   \<0.001
                                             No                             321                 64                       19.9   257    80.1   
  Rheumatism                                 Yes                            25                  19                       76     6      24     \<0.001
                                             No                             327                 100                      26.9   272    23.1   
  Infectious disease                         Yes                            22                  13                       59.1   9      40.9   0.002
                                             No                             375                 106                      28.3   269    71.7   
  Hypertension                               Yes                            97                  59                       60.8   38     39.2   \<0.001
                                             No                             300                 60                       20     240    80     
  History of eye disease except cataract     Yes                            72                  20                       27.8   52     72.2   0.653
                                             No                             325                 99                       30.5   226    69.5   
  History of eye surgery                     Yes                            72                  41                       56.9   31     43.1   \<0.001
                                             No                             325                 78                       24     247    76     
  History of penetrating trauma to the eye   Yes                            17                  10                       58.8   7      41.2   0.008
                                             No                             380                 109                      28.7   271    71.3   
  History of blunt trauma to the eye         Yes                            11                  3                        27.3   8      72.7   0.843
                                             No                             386                 116                      30.1   270    97.1   
  History of using steroid                   Yes                            29                  11                       37.9   18     62.1   0.331
                                             No                             368                 108                      29.3   260    70.7   
  History of using tranquilizers             Yes                            91                  43                       47.3   48     52.7   \<0.001
                                             No                             306                 76                       24.8   230    75.2   
  History of using aspirin                   Yes                            131                 57                       43.5   74     56.5   \<0.001
                                             No                             266                 62                       23.3   204    76.7   
  Taking vitamin supplements                 Yes                            83                  17                       20.5   66     79.5   0.034
                                             No                             314                 102                      32.5   212    67.5   
  Tobacco consumption                        Yes                            61                  18                       29.5   43     70.5   0.931
                                             No                             336                 101                      30.1   235    69.9   
  Alcohol use                                Yes                            9                   2                        22.2   7      77.8   0.608
                                             No                             388                 117                      30.2   271    69.8   
  Variables                                  Total number                   Infected cataract   *p* value (chi-square)                        
  Yes                                        No                                                                                               
  *n*                                        \%                             *n*                 \%                                            
  Work history in open environment           Yes                            158                 47                       29.7   111    70.3   0.936
                                             No                             239                 72                       30.1   167    69.9   
  History of living in the tropical areas    Yes                            56                  16                       28.6   40     71.4   0.805
                                             No                             341                 103                      30.2   238    69.8   
  Walking and exercising regularly           Yes                            188                 49                       26.1   139    73.9   0.107
                                             No                             209                 70                       33.5   139    66.5   
  History of repeated imaging of the head    Yes                            33                  16                       48.5   17     51.5   0.015
                                             No                             364                 103                      28.3   261    71.7   
  History of using artificial lenses         Yes                            26                  12                       46.2   14     53.8   0.063
                                             No                             371                 107                      28.8   264    71.2   
  High-fat diet                              Yes                            144                 45                       31.2   99     68.8   0.676
                                             No                             253                 74                       29.2   179    70.8   
  High vegetable consumption                 Yes                            292                 81                       27.7   211    72.3   0.105
                                             No                             105                 38                       36.2   67     63.8   
  High fruit consumption                     Yes                            310                 90                       29     220    71     0.439
  No                                         87                             29                  33.3                     58     66.7          
  Sun protection                             Yes                            129                 35                       27.1   94     72.9   0.391
                                             No                             268                 84                       31.3   184    68.7   
  Family history of cataract                 Yes                            91                  39                       42.9   52     57.1   0.002
                                             No                             306                 80                       26.1   226    73.9   

BMI, body mass index.

Adjusting the effect of potential confounders using multiple logistic regression models, the odds of developing cataract was higher in patients aged over 75 years \[odds ratio (OR) = 3.03, 95% CI: 1.21--7.59\], patients living alone (OR = 4.89, 95% CI: 1.86‒12.86), diabetic patients (OR = 19.10, 95% CI: 8.13--44.89), patients with rheumatoid arthritis (OR = 7.76, 95% CI: 2.32--25.99), patients having history of infectious diseases (OR = 4.02, 95% CI: 1.35‒11.98), hypertensive patients (OR = 3.19, 95% CI: 1.59--6.42), patients with history of ophthalmic surgery (OR = 2.83, 95% CI: 1.29--6.16), patients with history of sedative consumption (OR = 2.71, 95% CI: 1.35--5.47), patients using vitamin supplementation (OR = 0.21, 95% CI: 0.08--0.55), and patients with a positive familial history (OR = 2.81, 95% CI: 1.38--5.72). More than 53% of the variation in cataract development was explained by our final multivariate model ([Table 2](#table2-2515841419835339){ref-type="table"}).

###### 

Factors related with the prevalence of cataract after applying multiple logistic regression.

![](10.1177_2515841419835339-table2)

  Variables (references)                               OR                             CI            *p* value     
  ---------------------------------------------------- ------------------------------ ------------- ------------- -------
  Age group (60--64)                                   65--69                         1.12          0.49--2.53    0.779
                                                       70--74                         2.47          1.002--6.10   0.050
                                                       ⩾75                            3.03          1.21--7.59    0.018
  Education (higher diploma)                           Illiterate                     0.92          0.33--2.54    0.867
                                                       Primary education to diploma   1.30          0.56--3.04    0.539
  Job (employee)                                       Housewife                      0.58          0.25--1.34    0.201
                                                       Retired                        1.40          0.67--2.97    0.380
  Living condition (living with spouse and children)   Living alone                   4.89          1.86--12.86   0.001
                                                       Lives with spouse              1.65          0.81--3.35    0.169
  Diabetes mellitus (no)                               19.10                          8.13--44.89   \<0.001       
  Rheumatoid arthritis (no)                            7.76                           2.32--25.99   0.001         
  Infection disease (no)                               4.02                           1.35--11.98   0.013         
  Hypertension (no)                                    3.19                           1.59--6.42    0.001         
  History of eye surgery (no)                          2.83                           1.29--6.16    0.009         
  History of penetrating trauma to the eye (no)        2.10                           0.50--8.85    0.311         
  History of using tranquilizers (no)                  2.71                           1.35--5.47    0.005         
  History of using aspirin (no)                        0.61                           0.31--1.22    0.162         
  Taking vitamin supplements (no)                      0.21                           0.08--0.55    0.001         
  History of repeated imaging from the head (no)       1.06                           0.39--2.89    0.903         
  History of using lenses artificial (no)              0.96                           0.31--2.93    0.939         
  Family history of cataract (no)                      2.81                           1.38--5.72    0.004         

CI, confidence interval; OR, odds ratio.

It should be noted that although aspirin had a protective effect on developing cataract (*p* \< 0.001), controlling the effect of potential confounders showed no association between aspirin use and cataract (*p* = 0.162).

Discussion {#section9-2515841419835339}
==========

This cross-sectional study was conducted in an area with Mazandarani ethnicity in north of Iran. Our study showed that approximately 30% of over 60-year-old patients referred to the study day clinic had suffered from cataract. We also found that the chance of developing cataract was more common among patients aged over 75, single patients, diabetics, patients with rheumatoid arthritis, infectious diseases, hypertension, history of ophthalmic surgery, history of using sedatives, and familial history of cataract. In addition, the odds of cataract was lower among patients using vitamin supplementation.

In a population-based study conducted by Panday and colleagues,^[@bibr13-2515841419835339]^ during a 6-year period among population aged over 60, the incidence of cataract was 15.62% (45 out of 359). It was lower than that estimated in this study. However, we estimated the prevalence of cataract instead of the incidence reported in their study. In diseases such as cataract, the prevalence generally represents higher estimates than the incidence. Another reason for such heterogeneity was the difference in the study populations which was clinic based in our study. Tang and colleagues reported that the prevalence of cataract (cortical, nuclear, PSC, and post-surgical) among Chinese rural residences aged more than 45 was 44% (883 out of 2006). They also reported the prevalences of cataract among patients aged 60--64, 65--69, 70--74, 75--79, and over 80 at 53.5%, 74.2%, 77.4%, 90%, and 96.2%, respectively.^[@bibr14-2515841419835339]^ These estimates were higher than the estimates in this study. Another population-based study in India showed the age--sex standardized prevalence of operated and non-operated cataract as 72.7%.^[@bibr15-2515841419835339]^ The corresponding figure in a different population-based study carried out in China was 38.1%.^[@bibr16-2515841419835339]^ A cross-sectional study conducted in Oman among 11,413 people in 1997 showed the prevalence of cataract as 29.3 per 1000 population.^[@bibr17-2515841419835339]^ Prevalence of cataract among Taiwanese people aged more than 40 during the last decade (2001, 2009, and 2013) was 10.7% (2001), 13.3% (2009), and 11.84% (2013), respectively.^[@bibr18-2515841419835339]^

Prevalence of cataract among 35- to 64-year-old men and women in Lithuania was reported as 17.8% and 18.6%, respectively.^[@bibr19-2515841419835339]^ These rates were similar to the prevalence estimated in this study. In Chinese people aged more than 30, prevalences of cataract among the total population, men, and women were 20.8%, 17.6%, and 23.6%, respectively.^[@bibr20-2515841419835339]^ In South Korea, 42.28% of people aged more than 40 had cataract. The corresponding rates for Korean men and women were 40.82% and 43.62%, respectively.^[@bibr21-2515841419835339]^ Low estrogen level during menopause may be an explanation for lower risk of cataract in women.^[@bibr22-2515841419835339]^

Results of previous studies reporting the related factors of cataract are presented in [Table 3](#table3-2515841419835339){ref-type="table"}.^[@bibr13-2515841419835339],[@bibr15-2515841419835339],[@bibr21-2515841419835339],[@bibr23-2515841419835339][@bibr24-2515841419835339][@bibr25-2515841419835339][@bibr26-2515841419835339][@bibr27-2515841419835339][@bibr28-2515841419835339]--[@bibr29-2515841419835339]^ In the study conducted by Hankinson and colleagues (nurses health cohort), during 434,680-person-year follow-up, 448 patients with cataract were diagnosed. No protective effect of aspirin consumption for at least 20 years was found in that study.^[@bibr23-2515841419835339]^ That was in keeping with our study in which no effect of aspirin was observed in multivariate regression models. However, in univariate analysis, a significant effect was observed. It should be noted that the Hankinson and colleagues'^[@bibr23-2515841419835339]^ study was a prospective cohort which was expected to be more reliable than our cross-sectional study. In total, evidences regarding the protective effect of aspirin were low according to our comprehensive search.

###### 

Risk factors of cataract according to the results of the other studies.

![](10.1177_2515841419835339-table3)

  First authors                                                                              Country             Age group   Adjusted RR/HR/OR (CI 95%: Lower-Upper )                                                                                                                                                                                                                                                 
  ------------------------------------------------------------------------------------------ ------------------- ----------- ------------------------------------------ ----------------- ----------------- ----------------- ----------------- ----------------- ----------------- --------------------- ----------------- ----------------- ----------------- ----------------- ----------------- ----------------- -----------------
  Panday^[\*](#table-fn3-2515841419835339){ref-type="table-fn"}[@bibr13-2515841419835339]^   India               ⩾40         --                                         0.34(0.11-1.06)   1.77(1.08-2.88)   1.20(0.86-1.69)   2.47(1.73-3.52)   1.12(0.73-1.73)   0.99(0.64-1.53)   31.23(15.20-64.16)    1.75(1.17-2.61)   --                --                --                --                --                1.10(0.66-1.82)
  Vashist^[@bibr15-2515841419835339]^                                                        India               ⩾60         --                                         --                --                1.80(1.59-2.02)   --                --                --                8.04(6.48-9.97)       --                --                --                --                --                --                --
  Park^[@bibr21-2515841419835339]^                                                           Korean              =\>40       --                                         1.07(0.97-1.17)   1.11(0.94-1.31)   0.85(0.73-0.99)   1.08(0.84-1.38)   1.60(1.34-1.90)   1.22(1.09-1.37)   83.37(64.41-107.90)   1.24(1.10-1.40)   --                --                1.14(1.01-1.28)   --                --                --
  Hankinson^[@bibr23-2515841419835339]^                                                      USA                 --          1.31 (0.94-1.80)                           --                --                --                --                --                --                --                    --                --                --                --                --                --                --
  Glynn^[@bibr24-2515841419835339]^                                                          USA                 40-84       --                                         2.10(1.35-3.25)   --                --                --                --                --                --                    --                --                --                --                --                --                --
  Christen^[@bibr25-2515841419835339]^                                                       USA                 40-84       --                                         --                2.05(1.38-3.05)   --                --                --                --                --                    --                --                --                --                --                --                --
  Li^[@bibr26-2515841419835339]^                                                             Meta-analysis       --          --                                         --                --                --                --                1.97(1.45-2.67)   --                --                    --                --                --                --                --                --                --
  Theodoropoulou^[@bibr27-2515841419835339]^                                                 Greece              \>45        --                                         1.09(0.86-1.39)   1.99(1.23-3.23)   1.03(0.68-1.57)   --                --                --                6.40(3.84-10.68)      0.58(0.44-0.76)   --                --                --                --                --                --
  Yawson^[@bibr28-2515841419835339]^                                                         Ghana               =\>50       --                                         --                --                1.36(0.77-2.42)   0.93(0.59-1.44)   --                --                2.53(1.55-4.13)       1.37(0.88-2.14)   --                --                1.56(1.02-2.38)   --                0.47(0.10-2.19)   1.14(0.71-1.82)
  Prokofyeva^[@bibr29-2515841419835339]^                                                     literature review   40-95       --                                         --                2.34(1.07-5.15)   3.03(1.83-5.00)   --                2.72(1.72-4.28)   --                --                    --                2.00(1.35-2.98)   1.51(1.03-2.30)   --                3.25(1.39-7.58)   --                --

= Unadjusted.

Based on the results of the physician health cohort, BMI was a risk factor of cataract so that the risk of cataract was increased to 12% per two-unit higher BMI level.^[@bibr24-2515841419835339]^ This study did not show a significant effect of BMI.

Christen and colleagues indicated that in the above-mentioned cohort cigarette smoking was a risk factor for cataract which was in contrast to our results. Age difference of the study populations might be an explanation for such variation, because smoking is less common in the elderly.^[@bibr25-2515841419835339]^ Results of a meta-analysis showed that diabetic patients had approximately twofold higher chance of developing cataract compared with nondiabetic subjects^[@bibr26-2515841419835339]^ which is similar to our findings.

Results of a cohort reported an association between radiation particularly to head and neck following computed tomography (CT) and developing cataract. This study reported a 76% higher risk of cataract following imaging. It also showed that the frequency of cataract was increased with the number of CT scanning.^[@bibr30-2515841419835339]^ Although frequent imaging of the head increased the risk of cataract, controlling the effect of the confounders did not show a significant association.

A study carried out in Greece indicated that aging and cigarette smoking were the risk factors of cataract, while low literacy level was a protective factor.^[@bibr27-2515841419835339]^ Similarly, Yawson and colleagues^[@bibr28-2515841419835339]^ found old age as a risk factor for cataract among people over 50 in Ghana. A review study carried out in Europe showed that smoking, diabetes mellitus, multivitamin and corticosteroid consumption, female sex, and familial history of ophthalmic disorders increased the risk of cataract.^[@bibr29-2515841419835339]^ Finally, Park and colleagues^[@bibr21-2515841419835339]^ observed other factors such as low family income, low literacy level, hypertension, and old age as the risk factors for developing cataract.

This study was carried out among patients referring to a day clinic, and therefore the results might have poor reliability due to different characteristics of the study population with general population. Underestimation of some factors due to recall bias and self-reporting was another limitation of the study.

In conclusion, our study showed a relatively high prevalence of cataract in the study population. We also found aging, living alone, some infectious and noncommunicable disorders, ophthalmic surgery, sedatives, and positive familial history as the risk factors of cataract and vitamin supplements as the protective factor of cataract. Further prospective cohorts as well as clinical trials are recommended to help us in providing better estimates of the effects of these factors.

The authors would like to thank the research deputy of the Mazandaran University of Medical Sciences as well as the managers and ophthalmologists of the Imam Reza Clinic.

**Funding:** This study was carried out with Financial support of Mazandaran University of Medical Sciences, but the authors did not received financial support for the publication of this manuscript.

**Conflict of interest statement:** The authors declared no potential conflicts of interest with respect to the research, authorship, or publication of this article.

**ORCID iD:** Mahmood Moosazadeh ![](10.1177_2515841419835339-img1.jpg) <https://orcid.org/0000-0002-5452-514X>
